U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > News > Making a Difference > Project Example: Turmeric may treat retinitis pigmentosa eye disease Print

COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

Turmeric may treat retinitis pigmentosa eye disease

Close up of turmeric, an orange powder, in a small dish with a large wooden mixing spoon
Photo by Jeff Gray

Retinitis pigmentosa is a group of degenerative eye diseases caused by genetic mutations that lead to severe vision loss and blindness. Worldwide, more than one person in 4,000 is affected. Current experimental gene therapy involves injecting healthy copies of the culprit gene into patients' eyes. Although early clinical trials are promising, this approach is expensive and challenging, with more than 45 genetic mutations identified.

Recently, researchers supported by the NIH's National Eye Institute (NEI) found that curcumin, the active ingredient in the spice turmeric, may successfully treat some forms of retinitis pigmentosa. A study led by Dr. Radha Ayyagari, associate professor of ophthalmology at the University of California, San Diego, showed that curcumin prevented the abnormal and damaging protein build-up usually caused by a mutant gene.

The researchers investigated the P23H gene governing the protein rhodopsin, which eye rod cells need to detect light. With this mutation, the protein accumulates and eventually kills the cells. Previous research showed that curcumin inhibits build-up of the protein amyloid beta, thought to contribute to neuron destruction in Alzheimer’s disease.

"Coming from India I have a lot of faith in curcumin," Ayyagari said, explaining the compound has long been used to treat wounds and inflammation.

Many elderly Indian women in foreground and men in background seated on the floor, most wearing eye patches or bandages
Photo by Chris de Bode/WHO

India and China suffer the highest numbers
of blindness. The National Eye Institute
supports collaborations, partnerships and
training programs with these countries and
several others in research to prevent

The team found curcumin prevented mutant P23H rhodopsin from abnormally clustering in laboratory-cultured cells, so they fed the compound to rats genetically engineered to have the mutation. These rats, unlike control animals, showed reduced protein accumulation, which in turn preserved the number of retinal rods and cones and increased the light-induced electrical response in the rats' eyes.

Another benefit of curcumin is that unlike many drugs, it crosses the blood-retinal barrier, a protective meshwork of cells surrounding the retina. The researchers found curcumin had reached the rats' retinas after only two days of feeding. This suggests that patients with retinitis pigmentosa could simply take curcumin pills or include turmeric in their diet, rather than have a drug or a gene surgically injected into their eyes.

Unusual protein clustering may also be linked to eye diseases that affect other cells in the retina. The results reported by Ayyagari and her colleagues suggest that curcumin could treat all of these cases. But further work is needed to back up these preliminary findings and test which curcumin dosages are most effective.

More Information

Related Global Health Research Topics